CHEBI:28933 - (25R)-5β-spirostan-3β-ol

ChEBI IDCHEBI:28933
ChEBI Name(25R)-5β-spirostan-3β-ol
Stars
ASCII Name(25R)-5beta-spirostan-3beta-ol
DefinitionAn oxaspiro compound that is(5β,25R)-spirostan substituted by a β-hydroxy group at position 3.
Secondary ChEBI IDsCHEBI:9174, CHEBI:18536
Last Modified28 July 2014
DownloadsMolfile
FormulaC27H44O3
Net Charge0
Average Mass416.646
Monoisotopic Mass416.32905
SMILES[H][C@]12CC[C@]3([H])[C@]([H])(CC[C@@]4(C)[C@@]3([H])C[C@]3([H])O[C@]5(CC[C@@H](C)CO5)[C@@H](C)[C@]43[H])[C@@]1(C)CC[C@H](O)C2
InChIInChI=1S/C27H44O3/c1-16-7-12-27(29-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(28)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-24,28H,5-15H2,1-4H3/t16-,17+,18-,19+,20-,21+,22+,23+,24+,25+,26+,27-/m1/s1
InChIKeyGMBQZIIUCVWOCD-UQHLGXRBSA-N
Roles Classification
Biological Role:
metabolite  Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
Application:
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
ChEBI Ontology
Outgoing Relation(s)
(25R)-5β-spirostan-3β-ol (CHEBI:28933) has parent hydride (25R)-5β-spirostan (CHEBI:35535)
(25R)-5β-spirostan-3β-ol (CHEBI:28933) has role antineoplastic agent (CHEBI:35610)
(25R)-5β-spirostan-3β-ol (CHEBI:28933) has role metabolite (CHEBI:25212)
(25R)-5β-spirostan-3β-ol (CHEBI:28933) is a 3β-hydroxy steroid (CHEBI:36836)
(25R)-5β-spirostan-3β-ol (CHEBI:28933) is a organic heterohexacyclic compound (CHEBI:51914)
(25R)-5β-spirostan-3β-ol (CHEBI:28933) is a oxaspiro compound (CHEBI:37948)
(25R)-5β-spirostan-3β-ol (CHEBI:28933) is a sapogenin (CHEBI:26606)
Incoming Relation(s)
Ys-II (CHEBI:66497) has functional parent (25R)-5β-spirostan-3β-ol (CHEBI:28933)
Ys-IV (CHEBI:66498) has functional parent (25R)-5β-spirostan-3β-ol (CHEBI:28933)
IUPAC Name 
(3β,5β,25R)-spirostan-3-ol
Synonyms  Source
SmilageninKEGG COMPOUND
(25R)-5beta-Spirostan-3beta-olKEGG COMPOUND
(25R)-5beta-spirostan-3beta-olChEBI
IsosarsapogeninHMDB
Manual XrefsDatabases
C08913KEGG COMPOUND
LMST01080005LIPID MAPS
US2007191290Patent
UA81133Patent
HMDB0030048HMDB
KR20090007505Patent
KR20090009997Patent
C00003592KNApSAcK
Registry NumbersSources
Reaxys:91753Reaxys
CAS:126-18-1KEGG COMPOUND
CAS:126-18-1ChemIDplus
Citations